NUVB
USDNuvation Bio Inc. Class A Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$2.200
Máximo
$2.230
Mínimo
$1.800
Volumen
6.43M
Fundamentos de la Empresa
Capitalización de Mercado
615.9M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
4.17M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Wedbush Maintains Outperform on Nuvation Bio, Maintains $5 Price Target
Wedbush analyst David Nierengarten maintains Nuvation Bio with a Outperform and maintains $5 price target.
U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer
Approval follows Priority Review and is supported by the robust TRUST clinical program, in which IBTROZI treatment demonstrated high, durable response rates and brain-penetrant efficacy across different lines of
JMP Securities Reiterates Market Outperform on Nuvation Bio, Maintains $6 Price Target
JMP Securities analyst Silvan Tuerkcan reiterates Nuvation Bio with a Market Outperform and maintains $6 price target.
Acciones Relacionadas
HOPE
Hope Bancorp Inc.
PVL
Permianville Royalty Trust Trust Units
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNCO
AGNC Investment Corp. Depositary Shares each representing a 1/1000th interest in a share of 6.50% Series E Fixed-to-Floating Cumulative Redeemable Preferred Stock
BRBR
BellRing Brands Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.